Immune adjuvant effect of molecularly-defined toll-like receptor ligands

DN Toussi, P Massari - Vaccines, 2014 - mdpi.com
Vaccine efficacy is optimized by addition of immune adjuvants. However, although adjuvants
have been used for over a century, to date, only few adjuvants are approved for human use …

Glycosphingolipid functions

CA Lingwood - Cold Spring Harbor perspectives in …, 2011 - cshperspectives.cshlp.org
The combination of carbohydrate and lipid generates unusual molecules in which the two
distinctive halves of the glycoconjugate influence the function of each other. Membrane …

Recent advances in respiratory immunization: A focus on COVID-19 vaccines

X He, X Chen, H Wang, G Du, X Sun - Journal of Controlled Release, 2023 - Elsevier
The development of vaccines has always been an essential task worldwide since vaccines
are regarded as powerful weapons in protecting the global population. Although the vast …

Rational design of nasal vaccines

B Slütter, N Hagenaars, W Jiskoot - Journal of drug targeting, 2008 - Taylor & Francis
Nasal vaccination is a promising alternative to classical parental vaccination, as it is non-
invasive and, in principle, capable of eliciting strong systemic and local immune responses …

The use of layered double hydroxides as DNA vaccine delivery vector for enhancement of anti-melanoma immune response

A Li, L Qin, W Wang, R Zhu, Y Yu, H Liu, S Wang - Biomaterials, 2011 - Elsevier
Our previous studies have shown that Mg: Al 1: 1 layered double hydroxides (LDH (R1))
nanoparticles could be taken up by the MDDCs effectively and had an adjuvant activity for …

Cholera toxin, LT-I, LT-IIa and LT-IIb: the critical role of ganglioside binding in immunomodulation by type I and type II heat-labile enterotoxins

TD Connell - Expert review of vaccines, 2007 - Taylor & Francis
The heat-labile enterotoxins expressed by Vibrio cholerae (cholera toxin) and Escherichia
coli (LT-I, LT-IIa and LT-IIb) are potent systemic and mucosal adjuvants. Coadministration of …

Recombination among protein II genes of Neisseria gonorrhoeae generates new coding sequences and increases structural variability in the protein II family

TD Connell, WJ Black, TH Kawula… - Molecular …, 1988 - Wiley Online Library
Summary Expression of Neisseria gonorrhoeae Protein II (P. II) is subject to phase variation
and antigenic variation. The P. II proteins made by one strain possess both unique and …

Heat-labile enterotoxins as adjuvants or anti-inflammatory agents

S Liang, G Hajishengallis - Immunological investigations, 2010 - Taylor & Francis
Escherichia coli and Vibrio cholerae produce structurally related AB5-type heat-labile
enterotoxins, which are classified into two major types. The Type I subfamily includes …

Immunomodulation with enterotoxins for the generation of secretory immunity or tolerance: applications for oral infections

G Hajishengallis, S Arce, CM Gockel… - Journal of dental …, 2005 - journals.sagepub.com
The heat-labile enterotoxins, such as cholera toxin (CT), and the labile toxins types I and II
(LT-I and LT-II) of Escherichia coli have been extensively studied for their …

Different types of cell death induced by enterotoxins

CF Lin, CL Chen, WC Huang, YL Cheng, CY Hsieh… - Toxins, 2010 - mdpi.com
The infection of bacterial organisms generally causes cell death to facilitate microbial
invasion and immune escape, both of which are involved in the pathogenesis of infectious …